Search Results
14 results found-
CSL's Board requires that our codes and policies are adhered to by all relevant parties and are reviewed and updated on a regular basis.
https://www.csl.com/we-are-csl/corporate-governance/core-policies -
Veltassa® (patiromer) approved in Japan for the treatment of adults with hyperkalemia - Sep 24, 2024
Zeria expects to begin to market Veltassa ® following National Health Insurance price listing.
https://newsroom.csl.com/2024-09-24-Veltassa-R-patiromer-approved-in-Japan-for-the-treatment-of-adults-with-hyperkalemia -
ToVs which are part of the ordinary course of purchase and sale of medicinal products, such as discounts, price reductions and other trading devices
https://www.csl.com/-/media/shared/documents/vifor-disclosures/methodological-notes/methodological-note-template-2024_final.pdf